The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Current and emerging therapeutic targets for IBD
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
Colombel, J. F., Sandborn, W. J., Reinisch, W., Mantzaris, G. J., Kornbluth, A., Rachmilewitz, D., Lichtiger, S., D'Haens, G., Diamond, R. H., Broussard, D. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0904492 · Cited by 3,143
Ford Alexander, C., Paul, M., Hanauer Steven, B., 谭蓓, & Dong, W. Z. (2001) · Cited by 3,020
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P., Sands, B. E., Hanauer, S., Colombel, J.-F., Sandborn, W. J., Van Assche, G., Axler, J., Kim, H.-J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,888
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., Lukas, M., Fedorak, R. N., Lee, S., Bressler, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215739 · Cited by 2,719
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
Self-citationColombel, J., Sandborn, W. J., Rutgeerts, P., Enns, R., Hanauer, S. B., Panaccione, R., Schreiber, S., Byczkowski, D., Li, J., Kent, J. D., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.041 · Cited by 2,245
Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60026-9 · Cited by 2,154
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
Feagan, B. G., Sandborn, W. J., Gasink, C., Jacobstein, D., Lang, Y., Friedman, J. R., Blank, M. A., Johanns, J., Gao, L.-L., Miao, Y., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602773 · Cited by 1,845
Hueber, W., Sands, B. E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P. D. R., Wehkamp, J., Feagan, B. G., Yao, M. D., Karczewski, M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301668 · Cited by 1,547
IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542
Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499
Antibodies to interleukin 12 abrogate established experimental colitis in mice.
Neurath, M. F., Fuss, I., Kelsall, B. L., Stüber, E., & Strober, W. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1281 · Cited by 1,335
Self-citationAtreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Self-citationSandborn, W. J., van Assche, G., Reinisch, W., Colombel, J., D’Haens, G., Wolf, D. C., Kron, M., Tighe, M. B., Lazar, A., & Thakkar, R. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.032 · Cited by 1,269
D'Haens, G., Baert, F., van Assche, G., Caenepeel, P., Vergauwe, P., Tuynman, H., De Vos, M., van Deventer, S., Stitt, L., Donner, A., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60304-9 · Cited by 1,231
HELLER, F., FLORIAN, P., BOJARSKI, C., RICHTER, J., CHRIST, M., HILLENBRAND, B., MANKERTZ, J., GITTER, A., BURGEL, N., & FROMM, M. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.002 · Cited by 1,230
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
Sandborn, W. J., Gasink, C., Gao, L.-L., Blank, M. A., Johanns, J., Guzzo, C., Sands, B. E., Hanauer, S. B., Targan, S., Rutgeerts, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203572 · Cited by 1,134
Danese, S., & Fiocchi, C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1102942 · Cited by 1,102
Panés, J., García-Olmo, D., Van Assche, G., Colombel, J. F., Reinisch, W., Baumgart, D. C., Dignass, A., Nachury, M., Ferrante, M., Kazemi-Shirazi, L., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31203-x · Cited by 1,092
The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease
Van Assche, G., Van Ranst, M., Sciot, R., Dubois, B., Vermeire, S., Noman, M., Verbeeck, J., Geboes, K., Robberecht, W., & Rutgeerts, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051586 · Cited by 1,060
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
Pickert, G., Neufert, C., Leppkes, M., Zheng, Y., Wittkopf, N., Warntjen, M., Lehr, H.-A., Hirth, S., Weigmann, B., Wirtz, S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082683 · Cited by 1,043
Self-citationPanaccione, R., Ghosh, S., Middleton, S., Márquez, J. R., Scott, B. B., Flint, L., van Hoogstraten, H. J. F., Chen, A. C., Zheng, H., Danese, S., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.052 · Cited by 963
Sandborn, W. J., Feagan, B. G., Marano, C., Zhang, H., Strauss, R., Johanns, J., Adedokun, O. J., Guzzo, C., Colombel, J.-F., Reinisch, W., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.05.048 · Cited by 940
Natalizumab Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Colombel, J. F., Enns, R., Feagan, B. G., Hanauer, S. B., Lawrance, I. C., Panaccione, R., Sanders, M., Schreiber, S., Targan, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043335 · Cited by 927
Rossen, N. G., Fuentes, S., van der Spek, M. J., Tijssen, J. G., Hartman, J. H. A., Duflou, A., Löwenberg, M., van den Brink, G. R., Mathus-Vliegen, E. M. H., de Vos, W. M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.045 · Cited by 921
Colombel, J. F., Rutgeerts, P., Reinisch, W., Esser, D., Wang, Y., Lang, Y., Marano, C. W., Strauss, R., Oddens, B. J., Feagan, B. G., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.054 · Cited by 919
Methotrexate for the Treatment of Crohn's Disease
Feagan, B. G., Rochon, J., Fedorak, R. N., Irvine, E. J., Wild, G., Sutherland, L., Steinhart, A. H., Greenberg, G. R., Gillies, R., Hopkins, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320503 · Cited by 911
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
Sandborn, W. J., Hanauer, S. B., Katz, S., Safdi, M., Wolf, D. G., Baerg, R. D., Tremaine, W. J., Johnson, T., Diehl, N. N., & Zinsmeister, A. R. (2001) · Gastroenterology · doi:10.1053/gast.2001.28674 · Cited by 910
Powrie, F., Carlino, J., Leach, M. W., Mauze, S., & Coffman, R. L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2669 · Cited by 894
Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis
Günther, C., Martini, E., Wittkopf, N., Amann, K., Weigmann, B., Neumann, H., Waldner, M. J., Hedrick, S. M., Tenzer, S., Neurath, M. F., et al. (2011) · Nature · doi:10.1038/nature10400 · Cited by 884
Self-citationRachmilewitz, D., Katakura, K., Karmeli, F., Hayashi, T., Reinus, C., Rudensky, B., Akira, S., Takeda, K., Lee, J., Takabayashi, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.019 · Cited by 859
Anti–Interleukin-12 Antibody for Active Crohn's Disease
Mannon, P. J., Fuss, I. J., Mayer, L., Elson, C. O., Sandborn, W. J., Present, D., Dolin, B., Goodman, N., Groden, C., Hornung, R. L., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033402 · Cited by 848
Self-citationTiede, I., Fritz, G., Strand, S., Poppe, D., Dvorsky, R., Strand, D., Lehr, H. A., Wirtz, S., Becker, C., Atreya, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16432 · Cited by 828
Self-citationMechanisms of action of cyclosporine
Matsuda, S., & Koyasu, S. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00192-2 · Cited by 812
Mucosal healing in inflammatory bowel diseases: a systematic review
Neurath, M. F., & Travis, S. P. L. (2012) · Gut · doi:10.1136/gutjnl-2012-302830 · Cited by 810
Self-citationNatalizumab for Active Crohn's Disease
Ghosh, S., Goldin, E., Gordon, F. H., Malchow, H. A., Rask-Madsen, J., Rutgeerts, P., Vyhnálek, P., Zádorová, Z., Palmer, T., & Donoghue, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020732 · Cited by 808
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
Sandborn, W. J., Ghosh, S., Panes, J., Vranic, I., Su, C., Rousell, S., & Niezychowski, W. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112168 · Cited by 800
Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
Lee, J. S., Tato, C. M., Joyce-Shaikh, B., Gulen, M. F., Cayatte, C., Chen, Y., Blumenschein, W. M., Judo, M., Ayanoglu, G., McClanahan, T. K., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.003 · Cited by 760
Sandborn, W. J., Feagan, B. G., Fedorak, R. N., Scherl, E., Fleisher, M. R., Katz, S., Johanns, J., Blank, M., & Rutgeerts, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.014 · Cited by 753
Sandborn, W. J., Feagan, B. G., Marano, C., Zhang, H., Strauss, R., Johanns, J., Adedokun, O. J., Guzzo, C., Colombel, J., Reinisch, W., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.06.010 · Cited by 727
A Comparison of Methotrexate with Placebo for the Maintenance of Remission in Crohn's Disease
Feagan, B. G., Fedorak, R. N., Irvine, E. J., Wild, G., Sutherland, L., Steinhart, A. H., Greenberg, G. R., Koval, J., Wong, C. J., Hopkins, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006013422202 · Cited by 727
Van den Brande, J. M. H., Braat, H., van den Brink, G. R., Versteeg, H. H., Bauer, C. A., Hoedemaeker, I., van Montfrans, C., Hommes, D. W., Peppelenbosch, M. P., & van Deventer, S. J. H. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00382-2 · Cited by 723
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Jones, S. A., Scheller, J., & Rose-John, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57158 · Cited by 683
Differential Activity of IL-12 and IL-23 in Mucosal and Systemic Innate Immune Pathology
Uhlig, H. H., McKenzie, B. S., Hue, S., Thompson, C., Joyce-Shaikh, B., Stepankova, R., Robinson, N., Buonocore, S., Tlaskalova-Hogenova, H., Cua, D. J., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.05.017 · Cited by 682
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease
Schnitzler, F., Fidder, H., Ferrante, M., Noman, M., Arijs, I., Van Assche, G., Hoffman, I., Van Steen, K., Vermeire, S., & Rutgeerts, P. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20927 · Cited by 673
Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists
Scallon, B., Cai, A., Solowski, N., Rosenberg, A., Song, X.-Y., Shealy, D., & Wagner, C. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.418 · Cited by 672
Peripheral and Intestinal Regulatory CD4+CD25high T Cells in Inflammatory Bowel Disease
Maul, J., Loddenkemper, C., Mundt, P., Berg, E., Giese, T., Stallmach, A., Zeitz, M., & Duchmann, R. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.043 · Cited by 651
Heller, F., Fuss, I. J., Nieuwenhuis, E. E., Blumberg, R. S., & Strober, W. (2002) · Immunity · doi:10.1016/s1074-7613(02)00453-3 · Cited by 650
IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease
Geremia, A., Arancibia-Cárcamo, C. V., Fleming, M. P. P., Rust, N., Singh, B., Mortensen, N. J., Travis, S. P. L., & Powrie, F. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101712 · Cited by 640
Ito, H., Takazoe, M., Fukuda, Y., Hibi, T., Kusugami, K., Andoh, A., Matsumoto, T., Yamamura, T., Azuma, J., & Nishimoto, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.012 · Cited by 636
Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial
Targan, S. R., Feagan, B. G., Fedorak, R. N., Lashner, B. A., Panaccione, R., Present, D. H., Spehlmann, M. E., Rutgeerts, P. J., Tulassay, Z., Volfova, M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.024 · Cited by 614
Monteleone, G., Biancone, L., Marasco, R., Morrone, G., Marasco, O., Luzza, F., & Pallone, F. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70128-8 · Cited by 573
IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn’s disease
Kobayashi, T., Okamoto, S., Hisamatsu, T., Kamada, N., Chinen, H., Saito, R., Kitazume, M. T., Nakazawa, A., Sugita, A., Koganei, K., et al. (2008) · Gut · doi:10.1136/gut.2007.135053 · Cited by 570
Velayos, F. S., Terdiman, J. P., & Walsh, J. M. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41442.x · Cited by 548
Rousseaux, C., Lefebvre, B., Dubuquoy, L., Lefebvre, P., Romano, O., Auwerx, J., Metzger, D., Wahli, W., Desvergne, B., Naccari, G. C., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041948 · Cited by 526
Khanna, R., Bressler, B., Levesque, B. G., Zou, G., Stitt, L. W., Greenberg, G. R., Panaccione, R., Bitton, A., Paré, P., Vermeire, S., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00068-9 · Cited by 460
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
Vermeire, S., O'Byrne, S., Keir, M., Williams, M., Lu, T. T., Mansfield, J. C., Lamb, C. A., Feagan, B. G., Panes, J., Salas, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60661-9 · Cited by 452
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
Sandborn, W. J., Feagan, B. G., Wolf, D. C., D’Haens, G., Vermeire, S., Hanauer, S. B., Ghosh, S., Smith, H., Cravets, M., Frohna, P. A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1513248 · Cited by 452
Leppkes, M., Becker, C., Ivanov, I. I., Hirth, S., Wirtz, S., Neufert, C., Pouly, S., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G. D., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.018 · Cited by 444
Self-citationBryant, R. V., Burger, D. C., Delo, J., Walsh, A. J., Thomas, S., von Herbay, A., Buchel, O. C., White, L., Brain, O., Keshav, S., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309598 · Cited by 443
IL-6 is required for the development of Th1 cell-mediated murine colitis
Yamamoto, M., Yoshizaki, K., Kishimoto, T., & Ito, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4878 · Cited by 411
Gerlach, K., Hwang, Y., Nikolaev, A., Atreya, R., Dornhoff, H., Steiner, S., Lehr, H.-A., Wirtz, S., Vieth, M., Waisman, A., et al. (2014) · Nature Immunology · doi:10.1038/ni.2920 · Cited by 407
Self-citationHow Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy
Schett, G., Elewaut, D., McInnes, I. B., Dayer, J.-M., & Neurath, M. F. (2013) · Nature Medicine · doi:10.1038/nm.3260 · Cited by 406
Self-citationMongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease
Monteleone, G., Neurath, M. F., Ardizzone, S., Di Sabatino, A., Fantini, M. C., Castiglione, F., Scribano, M. L., Armuzzi, A., Caprioli, F., Sturniolo, G. C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1407250 · Cited by 401
Self-citationAtreya, R., Neumann, H., Neufert, C., Waldner, M. J., Billmeier, U., Zopf, Y., Willma, M., App, C., Münster, T., Kessler, H., et al. (2014) · Nature Medicine · doi:10.1038/nm.3462 · Cited by 392
Self-citationDesreumaux, P., Foussat, A., Allez, M., Beaugerie, L., Hébuterne, X., Bouhnik, Y., Nachury, M., Brun, V., Bastian, H., Belmonte, N., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.116 · Cited by 384
Picarella, D., Hurlbut, P., Rottman, J., Shi, X., Butcher, E., & Ringler, D. J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2099 · Cited by 362
Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation
Maxwell, J. R., Zhang, Y., Brown, W. A., Smith, C. L., Byrne, F. R., Fiorino, M., Stevens, E., Bigler, J., Davis, J. A., Rottman, J. B., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.019 · Cited by 342
Wessels, J. A. M., Huizinga, T. W. J., & Guchelaar, H.-J. (2007) · Rheumatology · doi:10.1093/rheumatology/kem279 · Cited by 337
Molendijk, I., Bonsing, B. A., Roelofs, H., Peeters, K. C. M. J., Wasser, M. N. J. M., Dijkstra, G., van der Woude, C. J., Duijvestein, M., Veenendaal, R. A., Zwaginga, J.-J., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.014 · Cited by 329
Fuss, I. J., Becker, C., Yang, Z., Groden, C., Hornung, R. L., Heller, F., Neurath, M. F., Strober, W., & Mannon, P. J. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000194183.92671.b6 · Cited by 326
Self-citationAllergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme
Krug, N., Hohlfeld, J. M., Kirsten, A.-M., Kornmann, O., Beeh, K. M., Kappeler, D., Korn, S., Ignatenko, S., Timmer, W., Rogon, C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411776 · Cited by 321
Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody.
Podolsky, D. K., Lobb, R., King, N., Benjamin, C. D., Pepinsky, B., Sehgal, P., & deBeaumont, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116575 · Cited by 320
Dulai, P. S., Singh, S., Jiang, X., Peerani, F., Narula, N., Chaudrey, K., Whitehead, D., Hudesman, D., Lukin, D., Swaminath, A., et al. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.236 · Cited by 320
New therapies for inflammatory bowel disease: from the bench to the bedside
Danese, S. (2012) · Gut · doi:10.1136/gutjnl-2011-300904 · Cited by 308
Herreros, M. D., Garcia-Arranz, M., Guadalajara, H., De-La-Quintana, P., & Garcia-Olmo, D. (2012) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0b013e318255364a · Cited by 303
A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease
Sandborn, W. J., Ghosh, S., Panes, J., Vranic, I., Wang, W., Niezychowski, W., Vermeire, S. A. R. A., Dewit, O., Peeters, H., Stehlik, J., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.01.029 · Cited by 300
Monteleone, G., Monteleone, I., Fina, D., Vavassori, P., Del Vecchio Blanco, G., Caruso, R., Tersigni, R., Alessandroni, L., Biancone, L., Naccari, G. C., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.042 · Cited by 293
Budesonide for induction of remission in Crohn's disease
Rezaie, A., Kuenzig, M. E., Benchimol, E. I., Griffiths, A. M., Otley, A. R., Steinhart, A. H., Kaplan, G. G., & Seow, C. H. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000296.pub4 · Cited by 260
Atreya, R., Zimmer, M., Bartsch, B., Waldner, M. J., Atreya, I., Neumann, H., Hildner, K., Hoffman, A., Kiesslich, R., Rink, A. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.08.032 · Cited by 256
Self-citationHealing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease
D'Haens, G., Geboes, K., Ponette, E., Penninckx, F., & Rutgeerts, P. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70027-1 · Cited by 246
Adalimumab Induces Deep Remission in Patients With Crohn's Disease
Colombel, J., Rutgeerts, P. J., Sandborn, W. J., Yang, M., Camez, A., Pollack, P. F., Thakkar, R. B., Robinson, A. M., Chen, N., Mulani, P. M., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.06.019 · Cited by 244
Withers, D. R., Hepworth, M. R., Wang, X., Mackley, E. C., Halford, E. E., Dutton, E. E., Marriott, C. L., Brucklacher-Waldert, V., Veldhoen, M., Kelsen, J., et al. (2016) · Nature Medicine · doi:10.1038/nm.4046 · Cited by 243
Aminosalicylates for induction of remission or response in Crohn's disease
Lim, W.-C., Wang, Y., MacDonald, J. K., & Hanauer, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008870.pub2 · Cited by 239
IL-23: a master regulator in Crohn disease
Neurath, M. F. (2007) · Nature Medicine · doi:10.1038/nm0107-26 · Cited by 239
Self-citationFantini, M. C. (2006) · Gut · doi:10.1136/gut.2005.072801 · Cited by 238
Vos, A. C. W., Wildenberg, M. E., Duijvestein, M., Verhaar, A. P., van den Brink, G. R., & Hommes, D. W. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.008 · Cited by 218
IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism
Eken, A., Singh, A. K., Treuting, P. M., & Oukka, M. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.33 · Cited by 202
Marshall, D. C., Lyman, S. K., McCauley, S., Kovalenko, M., Spangler, R., Liu, C., Lee, M., O’Sullivan, C., Barry-Hamilton, V., Ghermazien, H., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127063 · Cited by 201
Scaldaferri, F., Gerardi, V., Mangiola, F., Lopetuso, L. R., Pizzoferrato, M., Petito, V., Papa, A., Stojanovic, J., Poscia, A., Cammarota, G., et al. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i24.5505 · Cited by 194
Danese, S., Rudziński, J., Brandt, W., Dupas, J., Peyrin‐Biroulet, L., Bouhnik, Y., Kleczkowski, D., Uebel, P., Lukáš, M., Knutsson, M., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-308004 · Cited by 188
A role for sphingosine kinase 1 in dextran sulfate sodium‐induced colitis
Snider, A. J., Kawamori, T., Bradshaw, S. G., Orr, K. A., Gilkeson, G. S., Hannun, Y. A., & Obeid, L. M. (2009) · The FASEB Journal · doi:10.1096/fj.08-118109 · Cited by 186
Wyant, T., Leach, T., Sankoh, S., Wang, Y., Paolino, J., Pasetti, M. F., Feagan, B. G., & Parikh, A. (2015) · Gut · doi:10.1136/gutjnl-2014-307127 · Cited by 177
Reinisch, W., Hommes, D. W., Van Assche, G., Colombel, J.-F., Gendre, J.-P., Oldenburg, B., Teml, A., Geboes, K., Ding, H., Zhang, L., et al. (2006) · Gut · doi:10.1136/gut.2005.079434 · Cited by 175
Mucosal Barrier in Ulcerative Colitis and Crohn’s Disease
Dorofeyev, A. E., Vasilenko, I. V., Rassokhina, O. A., & Kondratiuk, R. B. (2013) · Gastroenterology Research and Practice · doi:10.1155/2013/431231 · Cited by 171
Van den Brande, J. M. H., Koehler, T. C., Zelinkova, Z., Bennink, R. J., te Velde, A. A., ten Cate, F. J. W., van Deventer, S. J. H., Peppelenbosch, M. P., & Hommes, D. W. (2007) · Gut · doi:10.1136/gut.2006.105379 · Cited by 170
Fischer, A., Zundler, S., Atreya, R., Rath, T., Voskens, C., Hirschmann, S., López-Posadas, R., Watson, A., Becker, C., Schuler, G., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310022 · Cited by 169
Self-citationStallmach, A., Langbein, C., Atreya, R., Bruns, T., Dignass, A., Ende, K., Hampe, J., Hartmann, F., Neurath, M. F., Maul, J., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13813 · Cited by 165
Self-citationReinisch, W., Panés, J., Khurana, S., Toth, G., Hua, F., Comer, G. M., Hinz, M., Page, K. M., O’Toole, M., Moorehead, T. M., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308337 · Cited by 163
Lasaro, M. A., Salinger, N., Zhang, J., Wang, Y., Zhong, Z., Goulian, M., & Zhu, J. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.01144-08 · Cited by 153
A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
Rutgeerts, P. J., Fedorak, R. N., Hommes, D. W., Sturm, A., Baumgart, D. C., Bressler, B. L., Schreiber, S., Mansfield, J. C., Williams, M. B., Tang, M. T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301769 · Cited by 152
A pathogenic role for T cell–derived IL-22BP in inflammatory bowel disease
Pelczar, P., Witkowski, M., Pérez, L. G., Kempski, J., Hammel, A., Brockmann, L., Kleinschmidt, D., Wende, S., Haueis, C., Bedke, T., et al. (2016) · Science · doi:10.1126/science.aah5903 · Cited by 146
Nighot, P. K., Al–Sadi, R., Rawat, M., Guo, S., Watterson, D. M., & Ma, T. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00256.2015 · Cited by 140
Biancheri, P., Brezski, R. J., Sabatino, A. D., Greenplate, A. R., Soring, K. L., Corazza, G. R., Kok, K. B., Rovedatti, L., Vossenkämper, A., Ahmad, N., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.002 · Cited by 132
Ordás, Í., Feagan, B. G., & Sandborn, W. J. (2011) · Gut · doi:10.1136/gutjnl-2011-300934 · Cited by 125
García‐Arranz, M., Herreros, M. D., González-Gómez, C. C., De-La-Quintana, P., Guadalajara, H., Georgiev-Hristov, T., Trébol, J., & García‐Olmo, D. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0356 · Cited by 125
Zundler, S., Schillinger, D., Fischer, A., Atreya, R. N., López-Posadas, R., Watson, A. J. M., Neufert, C. F., Atreya, I., & Neurath, M. F. (2016) · Gut · doi:10.1136/gutjnl-2016-312439 · Cited by 123
Self-citationTGF-β1 and Smad7 in the regulation of IBD
Monteleone, G., Boirivant, M., Pallone, F., & MacDonald, T. T. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.55 · Cited by 116
Allgayer, H. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.18.s2.1.x · Cited by 114
Th17-Related Cytokines in Inflammatory Bowel Diseases: Friends or Foes?
Monteleone, I., Sarra, M., Pallone, F., & Monteleone, G. (2012) · Current Molecular Medicine · doi:10.2174/156652412800620066 · Cited by 107
S1P signaling: new therapies and opportunities
Gonzalez‐Cabrera, P. J., Brown, S. D. M., Studer, S. M., & Rosen, H. (2014) · F1000Prime Reports · doi:10.12703/p6-109 · Cited by 104
Update on Janus Kinase Antagonists in Inflammatory Bowel Disease
Boland, B. S., Sandborn, W. J., & Chang, J. T. (2014) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2014.05.011 · Cited by 102
Th17-related cytokines: new players in the control of chronic intestinal inflammation
Monteleone, I., Pallone, F., & Monteleone, G. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-122 · Cited by 101
The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice
Deguchi, Y., Andoh, A., Yagi, Y., Bamba, S., Inatomi, O., Tsujikawa, T., & Fujiyama, Y. (2006) · Oncology Reports · doi:10.3892/or.16.4.699 · Cited by 91
Oancea, I., Movva, R., Das, I., de Cárcer, D. A., Schreiber, V., Yu, Y., Purdon, A. S., Harrington, B. S., Proctor, M. A., Wang, R., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310874 · Cited by 89
Popp, V., Gerlach, K., Mott, S., Turowska, A. M., Garn, H., Atreya, R. N., Lehr, H., Ho, I., Renz, H., Weigmann, B., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.09.005 · Cited by 87
Self-citationMeijer, M. J. W., Mieremet-Ooms, M. A. C., van Duijn, W., van der Zon, A. M., Hanemaaijer, R., Verheijen, J. H., van Hogezand, R. A., Lamers, C. B. H. W., & Verspaget, H. W. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20051 · Cited by 79
Atreya, R. N., Bloom, S. L., Scaldaferri, F., Gerardi, V., Admyre, C., Karlsson, A. E., Knittel, T. E., Kowalski, J. H., Lukáš, M., Löfberg, R., et al. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw103 · Cited by 76
Self-citationSelective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast
Gooderham, M., & Papp, K. A. (2015) · BioDrugs · doi:10.1007/s40259-015-0144-3 · Cited by 73
Rutella, S., Fiorino, G., Vetrano, S., Correale, C., Spinelli, A., Pagano, N., Arena, V., Maggiano, N., Repici, A., Malesci, A., et al. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.48 · Cited by 73
Saba, J. D., & Degagné, É. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s43453 · Cited by 68
Vedolizumab for induction and maintenance of remission in ulcerative colitis
Bickston, S. J., Behm, B. W., Tsoulis, D. J., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007571.pub2 · Cited by 66
Stremmel, W., Hanemann, A., Ehehalt, R., Karner, M., & Braun, A. (2010) · Digestive Diseases · doi:10.1159/000320407 · Cited by 62
Ciccocioppo, R., Cangemi, G. C., Kružliak, P., Gallia, A., Betti, E., Badulli, C., Martinetti, M., Cervio, M., Pecci, A., Bozzi, V., et al. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0122-1 · Cited by 58
Marinković, G., Hamers, A. A. J., de Vries, C. J. M., & de Waard, V. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000122 · Cited by 58
IL-17A directly inhibits TH1 cells and thereby suppresses development of intestinal inflammation
Awasthi, A., & Kuchroo, V. K. (2009) · Nature Immunology · doi:10.1038/ni0609-568 · Cited by 55
Sainathan, S. K., Bishnupuri, K. S., Aden, K., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21867 · Cited by 55
Juuti‐Uusitalo, K., Klunder, L. J., Sjollema, K. A., Ochodnicka‐Mackovicova, K., Ohgaki, R., Hoekstra, D., Dekker, J. P., & van IJzendoorn, S. C. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022967 · Cited by 53
Pivotal Role of Carbohydrate Sulfotransferase 15 in Fibrosis and Mucosal Healing in Mouse Colitis
Suzuki, K., Arumugam, S., Yokoyama, J., Kawauchi, Y., Honda, Y., Sato, H., Aoyagi, Y., Terai, S., Okazaki, K., Suzuki, Y., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158967 · Cited by 50
Self-citationVedolizumab for Ulcerative Colitis and Crohn’s Disease: Results and Implications of GEMINI Studies
Lam, M., & Bressler, B. L. (2014) · Immunotherapy · doi:10.2217/imt.14.66 · Cited by 48
Suzuki, K., Yokoyama, J., Kawauchi, Y., Honda, Y., Sato, H., Aoyagi, Y., Terai, S., Okazaki, K., Suzuki, Y., Sameshima, Y., et al. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw143 · Cited by 43
Self-citationTargeting IL-23 and Th17-Cytokines in Inflammatory Bowel Diseases
Nitto, D. D., Sarra, M., Cupi, M. L., Pallone, F., & Monteleone, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210794079164 · Cited by 39
Feuerstein, J. D. (2016) · Annals of Gastroenterology · doi:10.20524/aog.2016.0032 · Cited by 39
Nielsen, C. H., Albertsen, L., Bendtzen, K., et al. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03335.x · Cited by 29
Designer Thiopurine-analogues for Optimised Immunosuppression in Inflammatory Bowel Diseases
Atreya, I., Diall, A., Dvorský, R., Atreya, R. N., Henninger, C., Grün, M., Hofmann, U., Schaeffeler, E., López-Posadas, R., Daehn, I. S., et al. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw091 · Cited by 25
Self-citationMazur, M., Karczewski, J., Lodyga, M., et al. (2014) · Journal of Dermatological Treatment · doi:10.3109/09546634.2014.991267 · Cited by 20
Cyclosporine A Regulates Pro-Inflammatory Cytokine Production in Ulcerative Colitis
Steiner, S., Daniel, C., Fischer, A., Atreya, I., Hirschmann, S., Waldner, M. J., Neumann, H., Neurath, M. F., Atreya, R. N., & Weigmann, B. (2014) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-014-0309-7 · Cited by 18
Self-citationDanese, S., Vermeire, S., Hellstern, P., Panaccione, R., Rogler, G., FRASER, G. M., Kohn, A., Desreumaux, P., Leong, R. W. L., Comer, G. M., et al. (2016) · Cited by 7
Vermeire, S. A. R. A., Schreiber, S., Petryka, R., Kuehbacher, T., Hébuterne, X., Roblin, X., Kłopocka, M., Goldis, E.-A., Wisniewska-Jarosinska, M. A., Baranovsky, A., et al. (2016) · Cited by 5
Deterding, K., Spinner, C. D., Schott, E., Welzel, T. M., Gerken, G., Klinker, H., Spengler, U., Wiegand, J., Wiesch, J. S. Z., Pathil, A., et al. (2016) · United European Gastroenterology Journal · doi:10.1177/2050640616678364 · Cited by 5
Atreya, R. N., Neumann, H., Neufert, C. F., Waldner, M. J., Zopf, Y., Willma, M., App, C., Müunster, T., Kessler, H. P., Maas, S., et al. (2013) · Journal of Crohn s and Colitis · doi:10.1016/s1873-9946(13)60231-7 · Cited by 4
Self-citation
Cited by
Martin, J. C., Chang, C., Boschetti, G., Ungaro, R., Giri, M., Grout, J. A., Gettler, K., Chuang, L.-S., Nayar, S., Greenstein, A. J., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.008 · Cited by 872
Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease
Friedrich, M., Pohin, M., & Powrie, F. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.017 · Cited by 750
Zhang, M., Ma, Y., Ye, X., Zhang, N., Pan, L., & Wang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01464-x · Cited by 522
Janus kinase-targeting therapies in rheumatology: A mechanisms-based approach
Tanaka, Y., Luo, Y., O’Shea, J. J., & Nakayamada, S. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00726-8 · Cited by 501
The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond
Dostert, C., Grusdat, M., Letellier, E., & Brenner, D. (2019) · Physiological Reviews · doi:10.1152/physrev.00045.2017 · Cited by 498
Metadata
- Authors
- Neurath, M. F.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2017-02-01
- Volume
- 14
- Issue
- 5
- Pages
- 269-278
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2583464358
- Cited by
- 691
- References
- 143
- FWCI
- 7.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.